Scribd Logo
Upload

Welcome to Scribd!

  • 811 views

    Naprex Drug Study

    Uploaded by

    Angelica shane Navarro
    This document summarizes the drug study of a 75-year-old male patient diagnosed with acute respiratory failure secondary to aspiration pneumonia who was given the drug paracetamol. The drug works by inhibiting the enzyme cyclooxygenase and blocking prostaglandin production to reduce fever and provide analgesia. It was given intravenously at a dosage of 300mg every 4 hours as needed to reduce the patient's fever primarily due to his infection. Nursing responsibilities included monitoring for adverse reactions like hepatotoxicity and skin reactions and ensuring the daily dosage did not exceed 4g due to risk of liver damage.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd

    Naprex Drug Study

    Uploaded by

    Angelica shane Navarro
    811 views3 pages
    This document summarizes the drug study of a 75-year-old male patient diagnosed with acute respiratory failure secondary to aspiration pneumonia who was given the drug paracetamol. The drug works by inhibiting the enzyme cyclooxygenase and blocking prostaglandin production to reduce fever and provide analgesia. It was given intravenously at a dosage of 300mg every 4 hours as needed to reduce the patient's fever primarily due to his infection. Nursing responsibilities included monitoring for adverse reactions like hepatotoxicity and skin reactions and ensuring the daily dosage did not exceed 4g due to risk of liver damage.

    Copyright

    © © All Rights Reserved

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document summarizes the drug study of a 75-year-old male patient diagnosed with acute respiratory failure secondary to aspiration pneumonia who was given the drug paracetamol. The drug works by inhibiting the enzyme cyclooxygenase and blocking prostaglandin production to reduce fever and provide analgesia. It was given intravenously at a dosage of 300mg every 4 hours as needed to reduce the patient's fever primarily due to his infection. Nursing responsibilities included monitoring for adverse reactions like hepatotoxicity and skin reactions and ensuring the daily dosage did not exceed 4g due to risk of liver damage.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    811 views3 pages

    Naprex Drug Study

    Uploaded by

    Angelica shane Navarro
    This document summarizes the drug study of a 75-year-old male patient diagnosed with acute respiratory failure secondary to aspiration pneumonia who was given the drug paracetamol. The drug works by inhibiting the enzyme cyclooxygenase and blocking prostaglandin production to reduce fever and provide analgesia. It was given intravenously at a dosage of 300mg every 4 hours as needed to reduce the patient's fever primarily due to his infection. Nursing responsibilities included monitoring for adverse reactions like hepatotoxicity and skin reactions and ensuring the daily dosage did not exceed 4g due to risk of liver damage.

    Copyright:

    © All Rights Reserved
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 3

    DRUG STUDY

    Name: Juan dela Cruz Ward/Bed Number: 101 Attending Physician: Dr. Santos
    Age: 75 Impression/Diagnosis: Acute Respiratory Failure Type II Secondary to Aspiration Pneumonia
    Dosage,
    Mechanism of Adverse Special Nursing
    Name of Drug Route Freq., Indication
    Action Reactions Precautions Responsibilities
    Timing

    Generic: Dosage: Inhibits the enzyme Paracetamol is CV: Hypotension - Use - Examine the vial;
    Paracetamol 300mg cyclooxygenase, given to patient to acetaminophen don’t use if particulate
    blocking reduce fever that is EENT: Stridor cautiously in matter or discoloration
    Brand: prostaglandin primarily due to (parenteral form) patients with is observed.
    Naprex Route: IV production and infection related to hepatic
    interfering with pain pneumonia. ENDO: impairment or - Ensure that
    impulse generation Hypoglycemic active hepatic administration of
    Frequency: in the peripheral coma disease, acetaminophen will not
    -Stat order nervous system. alcoholism, exceed the
    -PRN Acetaminophen GI: Hepatotoxicity chronic recommended dosage
    -q4H also acts directly on malnutrition, of 4g/day because of
    temperature- HEME: Hemolytic severe the risk of liver
    Timing: regulating center in anemia (with long- hypovolemia, or damage
    the term use), severe renal
    hypothalamus by leukopenia, impairment. - Monitor patient for
    inhibiting synthesis neutropenia, serious skin reactions:
    of prostaglandin pancytopenia, - Monitor the end skin rash, redness, or
    E2. thrombocytopenia of a parenteral blisters; report to
    infusion to physician, drug should
    RESP: Atelectasis, prevent possibility be discontinued
    pulmonary edema of air embolism. immediately.

    SKIN: Acute - IV form is - Always prepare


    generalized contraindicated in Acetylcysteine
    exanthematous patients with (antidote) in case of
    pustulosis, severe hepatic Acetaminophen
    Stevens-Johnson impairment or toxicity occurrence.
    syndrome, toxic severe active liver
    epidermal disease. - Assess for clinical
    necrolysis improvement and relief
    - Use cautiously of fever.
    Other: Anaphylaxis, in patients with
    angioedema, any type of liver - Monitor patient input
    hypokalemia, disease, G6PD and output; decreasing
    hypomagnesemia deficiency, output may indicate
    Classification Contraindications Side Effects chronic renal failure
    malnutrition,
    Functional: Hypersensitivity to CNS: Agitation, severe - Assess for signs of
    Antipyretic, acetaminophen or anxiety, fatigue, hypovolemia hepatotoxicty
    nonopioid its components, fever, headache, (dehydration,
    analgesic severe hepatic insomnia blood loss), or
    impairment, severe severe renal
    active liver disease CV: Hypertension, impairment (CrCl
    peripheral edema of
    Chemical: 30 mL/minute or
    Nonsalicylate, GI: Abdominal pain, less).
    para- constipation,
    aminophenol diarrhea, jaundice, - Use cautiously
    derivative nausea, in patients with
    Vomiting long-term alcohol
    use because
    GU: Oliguria therapeutic doses
    (parenteral form) cause
    hepatotoxicity in
    MS: Muscle spasm these patients.
    (parenteral form) Chronic
    alcoholics
    RESP: Parenteral shouldn't take
    form: dyspnea, more than 2 g of
    plural effusion, acetaminophen
    wheezing every 24 hours.

    SKIN: Blisters,
    pruritus, rash,
    reddening, urticaria

    Other:
    hypersensitivity
    reactions; for
    parenteral
    form:
    hypoalbuminemia,
    hypophosphatemia,
    injection-site pain

    Student’s Name: _______________________________________________________________________________________________________


    References:___________________________________________________________________________________________________________
    Clinical Instructor: ______________________________________________________________________________________________________

    You might also like